A Conversation With Janet Woodcock, M.D. and Namandjé Bumpus, Ph.D. 2020 Science Writers' Boot Camp: The Biology of Why Certain Medications Don't Work African Americans Howard University Interviews Jaiya Patillo, Jackie Joyner-Kersee, Jennifer King, Dr. Namandje Bumpus
Dr. Namandjé N. Bumpus served as the FDA's Principal Deputy Commissioner until Decem, after joining the agency in August 2022 Recursion Bolsters Board of - Recursion Pharmaceuticals, Inc. Namandjé Bumpus, Ph.D.
Dr. Rosalind Franklin Centennial Series: Celebrating Dr. Rosalind Franklin's 100 Year Legacy hosted by Women in Science and Namandje Bumpus - Regulatory science and policy strategic advisor Dr. Namandjé N. Bumpus joined F-Prime in 2025, where she serves as a strategic advisor on regulatory science, regulatory affairs, and policy.
VERIFY: People with food allergies can safely get the COVID-19 vaccine Unlocking Complex Cell-Based Gene Therapies W. Montague Cobb, MD, PhD | STUFF YOU MISSED IN HISTORY CLASS
Measles, Drug Shortages, AI at FDA, and New Rare Disease Treatments | FDA In Your Day - Ep. 1 Check out the latest in our news video series FDA In Your Day! Today, Principal Deputy Commissioner Dr. Namandjé Bumpus Namandjé Bumpus, PhD, serves as a strategic advisor to investment firms, associations, academic medical centers, and pharmaceutical, beauty, biotech, and
Room at the Top: Leadership at the Federal Level Dr. Namandjé Bumpus shares some updates for the end of May in Episode 5 of FDA In Your Day. 0:00 Intro 0:05 Clinical Trials
In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman welcome Dr. Namandjé Bumpus, Principal Deputy Commissioner of Dr. Namandjé Bumpus, Ph.D. - Chief Scientist - U.S. Food and Drug Administration (FDA)
The ABCs of The FDA: America's Public Health Regulatory Agency FDA's Chief Scientist Dr. Namandjé N. Bumpus discusses formaldehyde and formaldehyde-releasing chemicals in FDA-regulated
One area I'm passionate about is STEM advocacy, especially for young people from my background. One thing I want do is to use Friends of Cancer Research (Friends) was proud to host this virtual meeting, Enhancing Diversity in Clinical Trials: Meet FDA's Chief Scientist, Dr. Namandjé Bumpus
Allergy Medicine For Your Children and Safety of Chemicals in Food | FDA In Your Day Ep. 2 #fda How I Got Started In Science: The K-12 Journey
Attention all early-career faculty members out there—this one's for you! This week on the Faculty Factory Podcast we are joined by Namandje Bumpus | Valproic Acid
Toward Personalizing HIV Treatment and Prevention Dr Namandjé Bumpus, PhD, Chief Scientist, Food and Drug Administration (FDA) - Regulatory Innovation VACCINE Q&A: Five top doctors answer your COVID-19 questions
I often get asked about my start in science, and parents asked how they can encourage their young people. I discuss my start in Epilepsy.com's contributors help practitioners understand the pharmacotherapeutics of cannabidiol in the treatment of epilepsy, A Covid-19 vaccine does not provide full or immediate protection, which means it's still possible to get infected and test positive for
Some of the common side effects of Depakote when treating complex partial seizures. Bumpus replaced agency veteran Janet Woodcock as principal deputy commissioner in February 2024. She was previously the FDA's chief Why have a career in STEM? Science is all around us!!
Enhancing Diversity in Clinical Trials: Implementation of Diversity Plans Chief Scientist at the FDA Answers YOUR Questions! What makes Johns Hopkins Immunogenetics Laboratory unique?
About Formaldehyde and Formaldehyde-Releasing Chemicals Obesity - Medications for an underestimated global threat | Tomorrow Today
Namandjé N. Bumpus is an American pharmacologist who served as the Principal Deputy Commissioner of the Food and Drug Administration. Namandje Bumpus | Drug Metabolism Meet our Chief Scientist, Dr. Namandjé N. Bumpus. Join her behind closed laboratory doors as we shine a spotlight on the
0:15 - Meeting Begins 3:10 - Opening Keynote from Namandjé Bumpus, U.S. FDA and Peter Marks, CBER, U.S. FDA 28:42 - The Namandjé Bumpus, FDA's No. 2 official, to depart agency at end of
Namandjé N. Bumpus, PhD - How Racism and Sexism Squash Talent and Slow Progress in STEM Depakote Side Effects The Importance Of Doing Career Day As A Black Scientist
Moderators: Namandjé Bumpus, PhD – Chief Scientist, Office of the Chief Scientist (OCS) at FDA Kuldev Singh, MD, MPH Moderated by FDA Foundation CEO Susan C. Winckler, RPh, Esq., this panel features Chief Scientist Namandjé Bumpus, PhD Datos sobre el formaldehído y las sustancias químicas que liberan formaldehído
Dr. Namandjé N. Bumpus served as the FDA's Principal Deputy Commissioner until December 31, 2024, after joining the agency in August 2022 as Chief Scientist. Janet Woodcock, M.D. and Namandjé Bumpus, Ph.D. talk about passing the torch as FDA's Principal Deputy Commissioner. How I Got My Start In Science
Johns Hopkins Medicine Dean/CEO Paul Rothman and Dr. Namandje Bumpus talk about her research, her plans for the Dr. Namandjé Bumpus, Ph.D. is U.S. Food and Drug Administration's (FDA) Chief Scientist Watch a longer version of the conversation between Johns Hopkins Medicine Dean/CEO Dr. Paul Rothman and Dr. Bill Moss,
Opioid Use Disorder, New Biosimilar, Black Family Cancer Awareness Week, & more | In Your Day Ep. 6 Researchers from Munich are trying to find out how the molecular transfer between fat cells, the pancreas and the brain works.
We know you have a ton of questions about COVID, vaccines and life after them. So we brought them to the experts to answer. Air date: Wednesday, May 4, 2022, 3:00:00 PM Description: NIH Director's Wednesday Afternoon Lecture Series [WALS] This is Various marginalized communities experience decreased access to health care. These communities are being marginalized even
Dr James Bumpus Discusses The City's Initiatives regarding enhancing opportunities for local small & minority businesses Small and Minority Business Director, Dr James Bumpus Black female Pharmacologist Namandje Bumpus is the Principal Deputy Commissioner at the US Food and Drug Administration
Namandjé N. Bumpus, PhD - F-Prime Capital Spina Bifida Has Been Associated With Depakote/Depakene (Valproic Acid)
Namandjé Bumpus, the US Food and Drug Administration's (FDA) principal deputy commissioner and second in command, will be leaving the agency at the end of the The Future of Clinical Trials, The Real Cost Campaign, and Sun Safety Tips | FDA In Your Day Ep. 5
AAU Alumni - Jackie Joyner Kersee Rosalind Franklin Society Presents: Center Stage: Science and Leadership from Bench to Boardroom With several incredible new
For A direct consult with Dr. Omar Danoun: Consults are for adults only, age 16 years and older because I am an adult neurologist Check out my new video series…FDA In Your Day! I'll regularly post videos with important updates from the agency. The first
The liver cells (magenta) of untreated obese mice (left) contain many large, white droplets of fat while those of obese mice treated 2024 CERSI Summit - Panel 4: FDA Center Directors Forum
Dr. Namandje Bumpus, Chief Scientist, Food and Drug Administration and Jason Steiner, PhD, Architect & Advisor — AI and Drug If you took Depakote or Depakene while pregnant and your child developed Spina Bifida, you may be eligible for compensation. If You're New Subscribe ▻ W. Montague Cobb, MD, PhD | STUFF YOU MISSED IN HISTORY
Dr. Namandjé Bumpus, FDA's Chief Scientist, shares her story about speaking out against bias, breaking the glass ceiling, and Namandjé Bumpus - Wikipedia youtubeshorts from @ProgressPotentialPossibilities Dr. Namandjé Bumpus, Ph.D., Chief Scientist, U.S. Food and Drug
Namandjé Bumpus Appointed As FDA Chief Scientist | Johns Quick Updates to Help Keep You Safe: Milk, Device Charging, & Sunscreen | FDA In Your Day Ep. 7 About Epilepsy and Cannabis: Pharmacotherapeutics
Navigating the Early-Career Faculty Years Allergy Medicine For Your Children and Safety of Chemicals in Food | FDA In Your Day Ep. 2
La Dra. Namandjé N. Bumpus, científica jefe de la FDA habla sobre el formaldehído y las sustancias químicas que liberan Namandjé Bumpus, director of the Department of Pharmacology and Molecular Sciences, is taking a leave of absence from Johns Hopkins to serve as the chief Notable Black Innovators: Namandje Bumpus PhD, Pharmacologist and Drug Metabolism Expert
I was recently invited to a Career Day at a school in Prince George's County, MD. In the following video, I talk about why I jumped Namandjé Bumpus, Strategic Advisor ‡ | Avalere
How AI Will Affect Drug Discovery and Healthcare with Dr. Namandje Bumpus & Jason Steiner, PhD Depakote and sleeping She is the only African American woman currently chairing a pharmacology department at any medical school in the nation.
Unbiased Science Podcast - The ABCs of The FDA: America's Public Health Regulatory Agency Ferrer, Poirot & Wansbrough | Depakote Birth Injury Namandjé Bumpus Makes History with New Department Chair Role
JHM Dean/CEO Paul Rothman Discusses Vaccines with Dr. Bill Moss (long version) If you took Depakote® while pregnant and your child suffered a birth defect, call Ferrer, Poirot & Wansbrough at 1-800-721-6800. Dr. Namandjé Bumpus Is Johns Hopkins University School Of Medicine's First Black Woman Dep
Dr. Bumpus gives some quick updates about recent FDA News. 0:00 Raw Milk 0:45 Medical Device Charging 1:13 Sunscreen Dean Rothman Talks with Namandje Bumpus, Director, Department of Pharmacology & Molecular Sciences Today we are putting a face to the FDA with a very special EXCLUSIVE interview with the FDA chief scientist, Dr. Namandjé
Here's why some people test positive after getting a Covid 19 vaccine Dr. Bumpus gives some quick updates about recent FDA News. You may be interested in these quick updates. I'm Dr. Namandjé Behind The Scenes In Our Labs With FDA Chief Scientist | Researching FDA
November 8th is National STEM Day! FDA Chief Scientist Namandjé Bumpus shares how a curiosity for the world around her led Panel Discussion with FDA leaders at the FDA Foundation Annual Public Meeting (May 24, 2023) Dr. Namandje Bumpus describes her work on how a group of proteins (cytochromes P450) alters drugs in the body, adding to
Deputy Commissioner Bumpus announces departure from FDA The Verify team works hard to get the facts out to our readers when you have important questions about COVID-19. We've (Airdate 11/13/2024) In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman welcome Dr. Namandjé Bumpus, Principal
Dr. Namandjé N. Bumpus serves as a strategic advisor to academic medical centers, investment firms, associations, and pharmaceutical, beauty, biotech, and